BIOMERICA INC

Biomerica develops and manufactures in vitro diagnostic test kits designed to analyze patient specimens including blood, urine, nasal swabs, and fecal samples. The company's products detect various diseases, food intolerances, and medical conditions by measuring specific bacteria, hormones, antibodies, antigens, and other substances present in human body fluids and tissues at trace concentrations. Its diagnostic portfolio includes tests for gastrointestinal diseases, food intolerances, and esoteric conditions. Notable products include InFoods IBS, a blood-based test that identifies patient-specific foods that may help alleviate irritable bowel syndrome symptoms, and hp+detect, a diagnostic test for Helicobacter pylori bacterial infection.

The company distributes its diagnostic products through physician offices, over-the-counter retail drugstores, and hospital and clinical laboratories. Biomerica operates at a modest scale with 53 full-time employees and is headquartered in Irvine, California. The company maintains a global distribution network, though the majority of its operations are concentrated in the United States. Founded in 1971 and incorporated in Delaware, Biomerica is listed on Nasdaq.